Suxia Han
- Cancer Research top 5%
- Cancer-related molecular mechanisms research 7
- Cancer, Lipids, and Metabolism 6
- Oncology top 10%
- Molecular Biology top 10%
- Ubiquitin and proteasome pathways 9
- RNA modifications and cancer 8
- Glycosylation and Glycoproteins Research 6
- DNA Repair Mechanisms 6
- Cell Biology top 10%
-
- Ferroptosis and cancer prognosis 7
-
- Nanoplatforms for cancer theranostics 6
- Co-authors
- Qing ZhuLiuyun GongJinlu MaMingzhen ZhangYujie ZhangMengjiao CaiChenchen HeChengcheng Liu
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Suxia Han
72 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 109
- Cancer Research 518
- Oncology 445
- Molecular Biology 1.0k
- Cell Biology 180
- Pulmonary and Respiratory Medicine 299
Countries citing papers authored by Suxia Han
This map shows the geographic impact of Suxia Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suxia Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suxia Han more than expected).
Fields of papers citing papers by Suxia Han
This network shows the impact of papers produced by Suxia Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suxia Han. The network helps show where Suxia Han may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Suxia Han, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 8 | |
| 3 | 2024 | 0 | |
| 4 | 2023 | 10 | |
| 5 | 2023 | 4 | |
| 6 | 2023 | 31 | |
| 7 | 2023 | 6 | |
| 8 | 2022 | 21 | |
| 9 | 2022 | 2 | |
| 10 | Application of Radiosensitizers in Cancer Radiotherapy | 2021 | 139 |
| 11 | 2021 | 24 | |
| 12 | 2021 | 9 | |
| 13 | 2020 | 4 | |
| 14 | 2020 | 4 | |
| 15 | 2018 | 47 | |
| 16 | 2018 | 20 | |
| 17 | 2013 | 6 | |
| 18 | 2013 | 43 | |
| 19 | 2012 | 36 | |
| 20 | 2011 | 17 |
About Suxia Han
Suxia Han is a scholar working on Cancer Research, Oncology, Molecular Biology, Pulmonary and Respiratory Medicine and Immunology, having authored 75 papers that have together received 1.8k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (9 papers), RNA modifications and cancer (8 papers), Ferroptosis and cancer prognosis (7 papers), Cancer-related molecular mechanisms research (7 papers), Glycosylation and Glycoproteins Research (6 papers), DNA Repair Mechanisms (6 papers), Nanoplatforms for cancer theranostics (6 papers) and Cancer, Lipids, and Metabolism (6 papers). The work is most often cited by research in Cancer Research (518 citations), Oncology (445 citations), Molecular Biology (1.0k citations), Cell Biology (180 citations) and Pulmonary and Respiratory Medicine (299 citations). Suxia Han has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Qing Zhu, Liuyun Gong, Jinlu Ma, Mingzhen Zhang, Yujie Zhang, Mengjiao Cai, Chenchen He, Chengcheng Liu, Yiping Dong and Congya Zhou. Their work appears in journals such as Oncotarget, Journal of Immunology Research, Oncology Reports, Frontiers in Oncology and Frontiers in Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.